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June Supplement 201182S AbstractsHey1, DLL4 xHes1, and Notch1 x Hes1; (p 0.01)] that
may confer CAD risk.
Conclusions: The Notch pathway is activated in ath-
erosclerotic plaques and results in endothelial inflammation
and senescence. Notch signaling may be linked to CAD
risk. These findings implicate, for the first time, a potential
involvement of Notch signaling in Atherosclerosis.
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Livingstone: Nothing to disclose; M. Pericak-Vance:
Nothing to disclose; D. M. Seo: Nothing to disclose; Y.
Tan: Nothing to disclose; R. Tian: Nothing to disclose; J.
Vance: Nothing to disclose; R. I. Vazquez-Padron:
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PS202.
Elevated Peri-Operative C-Reactive Protein Impedes
Late Vein Graft Remodeling
Yong He1, Peter Nelson1, Michael Hong1, Roger Tran-
Son-Tay1, Scott Berceli2. 1Surgery, University of Florida,
Gainesville, FL; 2Malcolm Randall VAMC, Gainesville, FL
Objectives: Enhanced systemic inflammation, as mea-
sured by C-reactive protein (CRP), has been associated
with reduced early outward remodeling and long-term vein
graft (VG) failure. This study seeks to define the long-term
changes in VG remodeling that are induced by this pro-
inflammatory phenotype.
Methods: A prospective study was performed on 31
patients undergoing autogenous VG placement. CT scans,
with computational analysis of wall shear stress (WSS), were
performed at 1wk, 1m, and 6m to evaluate lumen remod-
eling. hsCRP was obtained pre-op and 1wk post-op.
Results: Late changes in VG lumen diameter (between
1m to 6m) were negatively correlated with CRP levels
obtained at 1wk post-op (Fig A, P0.04), while early
changes in VG diameter (1wk and 1m) were independent
of 1wk CRP (Fig B, PNS). Adaptation of the lumen wasIositively correlated with WSS (Fig C, P0.001) and was
ot influenced by the 1wkCRP level (FigD, PNS). Neither
arly or late geometric VG changes nor the adaptive response
o WSS were correlated with pre-op CRP levels. Six (of 31)
G were revised or occluded within 1 year, and this was not
ependent on either pre-op or 1wk CRP.
Conclusions: Late VG remodeling was significantly
educed by an enhanced peri-operative inflammatory re-
ponse, while early VG adaptation was independent of this
esponse. In contrast to published reports, we found no
orrelation between the baseline inflammatory state of the
atient and WSS-dependent VG adaptation. The current
tudies suggest long-term structural modulation of the VG
y the inflammatory system as the dominant determinant
or these events.
uthor Disclosures: S. Berceli: Nothing to disclose; Y.
e: Nothing to disclose; M. Hong: Nothing to disclose;
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S204.
he Toll-like Receptor 2 Ligand HMGB-1 Contrib-
tes to Skeletal Muscle Damage in Critical Limb Isch-
mia
emanshu Patel1, Dhiraj Joshi1, Xu Shi-wen1, George
amilton1, David Abraham1, Daryll Baker1, Sidney Shaw2,
anice Tsui1. 1UCL, London, United Kingdom; 2Univer-
ity of Bern, Bern, Switzerland
Objectives: Inflammation and cell damage contribute to
he pathophysiology of critical limb ischemia (CLI). Toll-like
eceptors (TLRs) play an important role in inflammation and
issue damage probably in response to the release of endoge-
ous ligands.Wehypothesize that the expression of TLRs and
heir endogenous ligands is upregulated in ischaemic skeletal
uscle with consequent activation of their signaling pathway,
hich could lead to an increase in inflammatory cytokine
elease contributing to muscle damage.
Methods: TLR expression was studied in ischaemic
nd control human muscle biopsies and in C2C12 myo-
ubes cultured in ischaemic conditions using RT-PCR and
estern blot. Western blot was used tomeasure the expres-
ion of the endogenous ligand, high mobility group box
rotein-1 (HMGB-1). Functional effects of TLR2 antago-
ism on ischaemia-induced IL-6 release and cell death were
tudied by incubating myotubes with neutralizing TLR2
ntibody. IL-6 release was assayed by ELISA. Apoptosis
as assessed using cleaved caspase-3 and bax/bcl-2 ratio
easurements.
Results: TLR2 mRNA and protein expression was
ignificantly upregulated in ischaemic muscle and in
2C12 myotubes cultured in ischaemic conditions
p0.05). Raised levels of HMGB1 were demonstrated in
schaemic human muscle biopsies and in ischaemic C2C12
yotubes.TLR2 antagonism reduced ischaemia-induced
L-6 production and apoptosis in culture.
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Volume 53, Number 17S Abstracts 83SConclusions: Upregulation of TLR2 and HMGB-1
expression occurs in ischaemic muscle. Activation of
TLR2 signaling leads to IL-6 release which may contrib-
ute to inflammation and muscle damage. HMGB-1 inhi-
bition may be a potential target in reducing skeletal
muscle damage in CLI.
Author Disclosures: D. Abraham: Nothing to disclose;
D. Baker: Nothing to disclose; G. Hamilton: Nothing to
disclose; D. Joshi: Nothing to disclose; H. Patel: Nothing
to disclose; S. Shaw: Nothing to disclose; X. Shi-wen:
Nothing to disclose; J. Tsui: Nothing to disclose.
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“Back-Table” Manipulation of Human Saphenous
Vein Significantly Impairs Endothelial and Smooth
Muscle Function
Michael J. Osgood1, KyleM.Hocking1, KevinW. Sexton1,
Padmini Komalavilas2, Joyce Cheung-Flynn1, Marzia Le-
acche1, Susan Eagle1, Colleen Brophy2. 1Vanderbilt Uni-
versity Medical Center, Nashville, TN; 2Tennessee Valley
Veterans Affairs Medical Center, Nashville, TN
Objectives: Human saphenous vein (HSV) is the
most widely used arterial bypass conduit despite a high
rate of intimal hyperplasia (IH). IH is thought to evolve
as a response to vascular injury. We investigated whether
injury from back-table surgical preparation impairs HSV
endothelial and smooth muscle function.
Methods: HSV segments were collected from patients
undergoing arterial bypass. HSV was collected after surgi-
cal removal but before manipulation (unmanipulated,
UM). Additional HSV was collected after back-table ma-
nipulation, which included hand-held syringe distention
and marking for orientation (after manipulation, AM).
Paired UM and AM segments were obtained from 15
patients. HSV rings were suspended in amuscle bath. Force
measurements were obtained after administration of phen-
ylephrine (PE), sodium nitroprusside (SNP), and carbachol
(CCH).
Results: PE induced mean force of 0.070.04
N/m^2 in UM-HSV, versus 0.030.04 in AM-HSV
(p0.001). SNP induced smooth muscle dependent
relaxation of 53.923.9% in UM-HSV, versus
21.416.6 in AM-HSV (p0.0001, Figure). CCH in-
duced endothelial dependent relaxation of 19.912.5%
in UM-HSV, versus 0.76.3 in AM-HSV (p0.001,
Figure).
Conclusions: Back-table preparation causes injury
which markedly decreases HSV endothelial and smooth
muscle function. This argues for less injurious means of
distending and marking HSV grafts.
Author Disclosures: C. Brophy: Nothing to disclose;
J. Cheung-Flynn: Nothing to disclose; S. Eagle: Nothing to
disclose; K. M. Hocking: Nothing to disclose; P. Komala-
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oshua D. Arnold, Deidra J. Mountain, Stacy S. Kirkpat-
ick, David Cassada, Scott Stevens, Michael Freeman,
itchell Goldman, Oscar Grandas. University of Tennes-
ee Graduate School of Medicine, Knoxville, TN
Objectives: Gene therapy shows promise in the treat-
ent of vascular disease, but a formidable challenge has
een delivery of genetic material in a safe and non-toxic
ay. Viral transfection comes with significant clinical impli-
ations in terms of safety, and there are still no FDA-
pproved gene therapy products. This has led to recent
nterest in developing alternatives to viral transfection that
re low risk, predictable, and non-toxic. Biodegradable
olymers have shown promise as one of these alternatives,
ut to date have been exclusively tested in human stem
ells. Differentiated cell types would be prime targets for
herapeutic gene modulation in the prevention of various
isease processes. We aim to establish polymeric transfec-
igure. Percent relaxation of UM versus AM HSV in response to
NP (p0.0001), and CCH (p0.001).ion as a method of gene therapy in cells of vascular origin.
